CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device? Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education? Therapeutic Options for In-Stent Restenosis Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients? Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months versus aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicenter, open-label, randomized superiority trial Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database

Review ArticleVolume 64, Issue 23, December 2014

JOURNAL:J Am Coll Cardiol. Article Link

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

Rosenson RS, Davidson MH, Hirsh BJ et al. Keywords: atherosclerosis; cardiovascular disease; genetics; triglyceride; triglyceride-rich lipoproteins

FULL TEXT PDF